Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: Pooled analysis at the patient-level of 4 registries

JACC: Cardiovascular Interventions

Volumn 7, Issue 3, 2014, Pages 244-254

  De La Torre Hernandez, Jose M ^a   Baz Alonso, José A ^b   Gómez Hospital, Joan A ^c   Alfonso Manterola, Fernando ^d   Garcia Camarero, Tamara ^a   Gimeno De Carlos, Federico ^e   Roura Ferrer, Gerard ^c   Sanchez Recalde, Angel ^f   Martínez Luengas, Íñigo Lozano ^g   Gomez Lara, Josep ^c   Hernandez Hernandez, Felipe ^h   Pérez Vizcayno, María J ^d   Cequier Fillat, Angel ^c   Perez De Prado, Armando ⁱ   Gonzalez Trevilla, Agustín Albarrán ^h   Jimenez Navarro, Manuel F ^j   Mauri Ferre, Josepa ^k   Fernandez Diaz, Jose A ^l   Pinar Bermudez, Eduardo ^m   Zueco Gil, Javier ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL DO MEIXOEIRO   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^h HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

ⁱ HOSPITAL DE LEÓN   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^k HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^l HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^m HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

more..

Author keywords

drug eluting stent(s); intravascular ultrasound; left main coronary artery

Indexed keywords

ADULT; ARTICLE; CARDIOGENIC SHOCK; CORONARY ARTERY DISEASE; DEVICE THERAPY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPENSITY SCORE; REVASCULARIZATION; THROMBOSIS; AGED; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DISEASE REGISTRY; EVENT FREE SURVIVAL; HAZARD RATIO; INCIDENCE; RETROSPECTIVE STUDY; SPAIN; TARGET LESION REVASCULARIZATION; TREATMENT OUTCOME; BLOOD VESSEL TRANSPLANTATION; CLINICAL TRIAL; COMPUTER ASSISTED SURGERY; ENDOSCOPIC ECHOGRAPHY; EPIDEMIOLOGY; HEART MUSCLE REVASCULARIZATION; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REGISTER; SURVIVAL RATE; TRENDS;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MYOCARDIAL REVASCULARIZATION; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; REGISTRIES; SPAIN; SURGERY, COMPUTER-ASSISTED; SURVIVAL RATE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84896511045     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2013.09.014     Document Type: Article

References (21)

1. Sanmartin M, Baz JA, Lozano I, et al. One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: results of a multicenter registry. Catheter Cardiovasc Interv 2007;69:372-7. (Pubitemid 46339278)
2. Vaquerizo B, Lefèvre T, Darremont O, et al. Unprotected left main stenting in the real world: two-year outcomes of the French left main Taxus registry. Circulation 2009;119:2349-56.
3. Chieffo A, Magni V, Latib A, et al. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions: the Milan experience. J Am Coll Cardiol Intv 2010;3:595-601.
4. Park DW, Seung KB, Kim YH, et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol 2010;56:117-24.
5. Onuma Y, Girasis C, Piazza N, et al. Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) registries. J Am Coll Cardiol Intv 2010;3:584-94.
6. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010;121:2645-53.
7. Kappetein AP, Feldman TE, Mack MJ, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011;32:2125-34.
8. Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011;364:1718-27.
9. Capodanno D, Stone GW, Morice MC, Bass TA, Tamburino C. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. J Am Coll Cardiol 2011;58:1426-32.
10. Alfonso F. Left main coronary artery stenting: crossing the Rubicon. J Am Coll Cardiol 2009;53:1769-72.
11. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58:e44-122.
12. Díaz JF, de La Torre JM, Sabaté M, Goicolea J. Spanish Cardiac Catheterization and Coronary Intervention Registry. 21st official report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2011). Rev Esp Cardiol (Engl Ed) 2012;65:1106-16.
13. Agostoni P, Valgimigli M, Van Mieghem CA, et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol 2005;95:644-7. (Pubitemid 40255259)
14. Park SJ, Kim YH, Park DW, et al., MAIN-COMPARE Investigators. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2009;2:167-77.
15. Puri R, Kapadia SR, Nicholls SJ, Harvey JE, Kataoka Y, Tuzcu EM. Optimizing outcomes during left main percutaneous coronary intervention with intravascular ultrasound and fractional flow reserve: the current state of evidence. J Am Coll Cardiol Intv 2012;5:697-707.
16. Alfonso F, Dutary J, Zakhem B. Letter regarding article "Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis." Circ Cardiovasc Interv 2009;2:e3.
17. de la Torre Hernandez JM, Alfonso F, Recalde AS, et al. Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry). Am J Cardiol 2013;111:676-83.
18. Gómez-Hospital JA, Gomez-Lara J, Rondan J, et al. Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery. Rev Esp Cardiol (Engl Ed) 2012;65:530-7.
19. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. (Pubitemid 46685903)
20. Park SJ, Kim YH, Lee BK, et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 2005;45:351-6.
21. Park DW, Kim YH, Yun SC, et al. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) registry. J Am Coll Cardiol 2010;56:1366-75.